BlueMtec

Seongnam-si, South Korea Founded: 2015 • Age: 11 yrs Listed
Provider of prescription medicine AI platform for medical supplies and consumables in the healthcare industry

About BlueMtec

BlueMtec is a publicly listed company based in Seongnam-si (South Korea) founded in 2015. Its chief executive, as recorded, is Hyunsoo Kim. Its website bluemtec.com draws about 69 thousand monthly visits. Its focus areas include HealthTech, Healthcare IT, Provider and Administrative Solutions. Its competitors include Ahn-Gook Pharmaceutical, Taejeon Group and Blue Farm Korea.

Company details

Provider of prescription medicine AI platform for medical supplies and consumables in the healthcare industry. It also provide services such as online purchasing systems, website developmentmarketing, and B2B platforms.

  • Headquarters Seongnam-si, South Korea
  • Stage Public
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website bluemtec.com
Key Metrics

Funding Insights of BlueMtec

  • Total Rounds 1
  • Investors Count 1

All 1 funding rounds of BlueMtec with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2019Seed–New Paradigm Investment
–
Valuation history

1 investors in total: 1 institutional.

Investors in BlueMtec

BlueMtec has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include New Paradigm Investment.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
npinvestment.co.kr
Premium access

Investor details for BlueMtec

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of BlueMtec

2 people are tracked at BlueMtec (2 in leadership).

NameRoleGroup
Hyunsoo Kim
Co-CEOLeadership
Byungchan Jung
Co-CEOLeadership
Premium access

Complete people profiles for BlueMtec

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of BlueMtec

BlueMtec is a publicly listed company on the KRX with ticker symbol 439580 in South Korea, operating in the Distribution services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date13 Dec 2023
  • Listed onKRX: 439580
  • Listed entityBLUEMTEC CO. LTD.
  • Exchange sectorDistribution services

Timeline of BlueMtec

3 dated milestones of BlueMtec across 8 years, from founding to its latest funding, stage changes and deals.

  1. Founded BlueMtec is founded.
  2. Funding First funding round.
  3. IPO Lists on the stock exchange (IPO).

Competitors of BlueMtec

BlueMtec has 3 listed competitors in our database. They include Ahn-Gook Pharmaceutical, Taejeon Group and Blue Farm Korea.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
ahn-gook.com1955Seoul, South Korea
Pharmaceutical products
taejeongroup.com1935Jeonju, South Korea
Distributes a variety of pharmaceutical drugs.
bluepharmkorea.co.kr2015Seoul, South Korea
Online platform for purchasing pharmaceuticals and medical supplies for hospitals.
Premium access

Detailed competitors of BlueMtec

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of BlueMtec

The website of BlueMtec (bluemtec.com) receives about 69K visits a month.

  • Monthly visits
    69K

    ▲ 43% vs previous month

Similar websites

Websites whose visitors overlap most with BlueMtec. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
bluepharmkorea.co.kr
100%
153.7K#200,197View details
google.com
68%
85.8B#1View details
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Bluemtec

Blue M -Tech invests in Medis Taff
Venturesquare β€’ 2 years ago
Premium access

Complete news archive for BlueMtec

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about BlueMtec

BlueMtec was founded in 2015 and raised its 1st funding round 4 years after it was founded.

BlueMtec is headquartered in Seongnam-si, South Korea. It is registered at Seongnam-si, Gyeonggi-do, South Korea.

Hyunsoo Kim is the CEO of BlueMtec, as recorded in our data.

Provider of prescription medicine AI platform for medical supplies and consumables in the healthcare industry. It also provide services such as online purchasing systems, website developmentmarketing, and B2B platforms.

BlueMtec's top competitors include Ahn-Gook Pharmaceutical, Taejeon Group and Blue Farm Korea.

Yes, BlueMtec is publicly traded on KRX under the ticker symbol 439580.

BlueMtec has 1 investor. Key investors include New Paradigm Investment.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available